Hepatic enzyme induction and vitamin K1 elimination in man. 1987

A K Scott, and B P Haynes, and K D Schinkel, and E E Ohnhaus, and B K Park
Department of Medicine and Therapeutics, University of Aberdeen, Scotland.

We have studied the effect of hepatic enzyme induction on vitamin K1 elimination in patients on long-term anticonvulsant therapy and in volunteers given rifampicin. Neither the anticonvulsants (phenytoin and phenobarbitone) nor rifampicin had any significant effect on vitamin K1 elimination half-life or AUC. The neonatal haemorrhage which occurs in babies born to mothers on long-term enzyme inducing drugs is unlikely to be related to an increased rate of vitamin K elimination in the mother.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin
D014812 Vitamin K A lipid cofactor that is required for normal blood clotting. Several forms of vitamin K have been identified: VITAMIN K 1 (phytomenadione) derived from plants, VITAMIN K 2 (menaquinone) from bacteria, and synthetic naphthoquinone provitamins, VITAMIN K 3 (menadione). Vitamin K 3 provitamins, after being alkylated in vivo, exhibit the antifibrinolytic activity of vitamin K. Green leafy vegetables, liver, cheese, butter, and egg yolk are good sources of vitamin K.

Related Publications

A K Scott, and B P Haynes, and K D Schinkel, and E E Ohnhaus, and B K Park
July 1984, British journal of clinical pharmacology,
A K Scott, and B P Haynes, and K D Schinkel, and E E Ohnhaus, and B K Park
December 1983, British journal of clinical pharmacology,
A K Scott, and B P Haynes, and K D Schinkel, and E E Ohnhaus, and B K Park
July 1959, Lyon medical,
A K Scott, and B P Haynes, and K D Schinkel, and E E Ohnhaus, and B K Park
April 1979, British journal of clinical pharmacology,
A K Scott, and B P Haynes, and K D Schinkel, and E E Ohnhaus, and B K Park
February 1977, Proceedings of the Royal Society of Medicine,
A K Scott, and B P Haynes, and K D Schinkel, and E E Ohnhaus, and B K Park
December 1978, British journal of clinical pharmacology,
A K Scott, and B P Haynes, and K D Schinkel, and E E Ohnhaus, and B K Park
July 1974, Irish journal of medical science,
A K Scott, and B P Haynes, and K D Schinkel, and E E Ohnhaus, and B K Park
January 1979, Acta medica Academiae Scientiarum Hungaricae,
A K Scott, and B P Haynes, and K D Schinkel, and E E Ohnhaus, and B K Park
June 1971, Clinical science,
A K Scott, and B P Haynes, and K D Schinkel, and E E Ohnhaus, and B K Park
October 1978, Clinical science and molecular medicine,
Copied contents to your clipboard!